Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Laurence E. McCahill"'
Publikováno v:
Case Reports in Dermatology, Vol 16, Iss 1, Pp 75-82 (2024)
Introduction: Basal cell carcinoma (BCC) is the most common skin malignancy in the world. While most lesions are treated using surgical methods, others may present as locally advanced or metastatic disease and are not amenable to surgical therapy alo
Externí odkaz:
https://doaj.org/article/e1c0930e1d6c46f3b368966b3a48f37a
Publikováno v:
American journal of surgery.
Reoperation is associated with unfavorable outcomes and increased healthcare utilization. This study seeks to investigate the incidence and factors related to reoperation in patients undergoing urgent/emergent colectomies.The Michigan Surgical Qualit
Autor:
Sarat C. Khandavalli, Jensen B. Jantz, Laurence E. McCahill, Mark S. Kosten, Barrett A. Kielhorn, Stephen S Phillips
Publikováno v:
The American Journal of Surgery. 217:527-531
Introduction Adherence to guideline-based care for melanoma remains suboptimal. This study describes the development of a quality monitoring program and compares the quality of care before and after its implementation. Methods Thirty quality metrics
Autor:
Adedayo A Onitilo, Jill K Onesti, Richard M Single, Jessica M Engel, Ted A James, Erin J Aiello Bowles, Heather Spencer Feigelson, Tom Barney, Laurence E McCahill
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84535 (2013)
BACKGROUND: Treatment with neoadjuvant chemotherapy (NAC) has made it possible for some women to be successfully treated with breast conservation therapy (BCT ) who were initially considered ineligible. Factors related to current practice patterns of
Externí odkaz:
https://doaj.org/article/a86063f7b4834016874139fa64ce1603
Publikováno v:
Rare Tumors, Vol 1 (2009)
Primary hepatic angiosarcoma is a rare and rapidly fatal disease. We present the highly unusual identification of this lesion five years after the initial clinical presentation. In 2003, a 32-year-old man presented with abdominal pain, tachycardia, a
Externí odkaz:
https://doaj.org/article/ad583c7cb90f4cc88027871965de180a
Autor:
Shawn H. Obi, Mathew H. Chung, Samantha Hendren, Richard Berri, Sandra L. Wong, Laurence E. McCahill, Mark A. Healy, David Kwon, Hiromichi Ito
Publikováno v:
Annals of Surgical Oncology. 23:3047-3055
Fluid administration practices may affect complication rates in some abdominal surgeries, but effects in patients undergoing pancreatectomy are not understood well. We sought to determine whether amount of intraoperative fluid administered to patient
Autor:
Robert W. Krell, Sandra L. Wong, David Kwon, Darrell A. Campbell, Laurence E. McCahill, Zaid M. Abdelsattar, Mark A. Healy, Timothy L. Frankel, Samantha Hendren
Publikováno v:
Annals of Surgical Oncology. 22:2468-2474
A strong relationship between hospital caseload and adverse outcomes has been demonstrated for pancreatic resections. Participation in regional surgical collaboratives may mitigate this phenomenon. This study sought to investigate changes over time i
Autor:
Robert R. Gerard, Andrew J. Mullard, Barrett A. Kielhorn, Laurence E. McCahill, Brent Petersen
Publikováno v:
American journal of surgery. 215(4)
We sought to decrease organ space infection (OSI) following appendectomy for perforated acute appendicitis (PAA) by minimizing variation in clinical management.A postoperative treatment pathway was developed and four recommendations were implemented:
Publikováno v:
Clinical Journal of Oncology Nursing. 18:193-198
Gastrointestinal (GI) cancer is the second most frequent cancer diagnosis in the United States, and the care for patients with GI cancer is multifaceted, with each clinical encounter impacting patients' overall experience. Patients and families often
Autor:
Thomas A. Roland, Chelsea L. Carman, David N. Krag, Laurence E. McCahill, Yu-Jing Sun, Elena Peletskaya, Girja S. Shukla, Stephanie C. Pero
Publikováno v:
Cancer Immunology, Immunotherapy. 62:1397-1410
Phage display is a powerful method for target discovery and selection of ligands for cancer treatment and diagnosis. Our goal was to select tumor-binding antibodies in cancer patients. Eligibility criteria included absence of preexisting anti-phage a